O'Shaughnessy Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-140	Closed	-$5K	–	2767
2021 Q1	$5K	Hold	140	–	–	﹤0.01%	1945
2020 Q4	$2K	Hold	140	–	–	﹤0.01%	1876
2020 Q3	$1K	Hold	140	–	–	﹤0.01%	1844
2020 Q2	$1K	Buy	+140	New	+$577	﹤0.01%	1699
2017 Q2	–	Sell	-577	Closed	-$21K	–	995
2017 Q1	$21K	Sell	577 -400	-41%	-$17.6K	﹤0.01%	736
2016 Q4	$49K	Sell	977 -34	-3%	-$1.79K	﹤0.01%	715
2016 Q3	$53K	Buy	1,011 +215	+27%	+$10.3K	﹤0.01%	688
2016 Q2	$33K	Buy	+796	New	+$34.6K	﹤0.01%	724

O'Shaughnessy Asset Management's FPRX Position: Q2 2021 in Review

O'Shaughnessy Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 140 shares — an estimated $5K sold.

O'Shaughnessy Asset Management first reported a position in FPRX in Q2 2016 and held it in 8 quarters. The position peaked at $53K in Q3 2016. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

O'Shaughnessy Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 140 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $5K.
O'Shaughnessy Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 8 quarters.
O'Shaughnessy Asset Management's Five Prime Therapeutics, Inc. position peaked at $53K in Q3 2016.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.